Back to Journals » Therapeutics and Clinical Risk Management » Volume 5

Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency

Total article views   HTML views PDF downloads Totals
14,706 Dovepress* 14,706+ 2,890 17,596
Totals 14,706 2,890 17,596
*Since 16 July 2009
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 0 12

View citations on Google Scholar